Literature DB >> 12543195

Pseudotumor cerebri induced by minocycline therapy for acne vulgaris.

Kiyofumi Mochizuki1, Tomoko Takahashi, Michihisa Kano, Keiichi Terajima, Nobuhide Hori.   

Abstract

BACKGROUND: We report a case of a young girl who developed pseudotumor cerebri while taking minocycline for acne vulgaris. CASE: A 16-year-old girl without a history of menstrual irregularity, weighing 60 kg (body mass index: 26.0%) presented with a history of 1 week of headache and sudden onset of a horizontal diplopia. OBSERVATION: Examination revealed bilateral papilledema and an abduction deficit in her right eye. Her cerebrospinal fluid had an opening pressure of 400 mm H(2)O and a normal composition. Following normal findings on computed tomography and magnetic resonance imaging, a diagnosis of pseudotumor cerebri was made. She reported receiving minocycline to treat acne vulgaris during the previous 3 weeks. The headache resolved with withdrawal of minocycline. The diplopia and papilledema resolved after two lumbar punctures, although the visual field defects persisted. The minocycline concentrations in the serum and cerebrospinal fluid taken after cessation of the drug were below the detectable level.
CONCLUSION: The role of minocycline should be considered and routine ophthalmologic examination during minocycline treatment should be performed when pseudotumor cerebri occurs in patients treated for acne vulgaris.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12543195     DOI: 10.1016/s0021-5155(02)00550-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  2 in total

Review 1.  Pseudotumor cerebri.

Authors:  Paul W Brazis
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

2.  Minocycline-associated pseudotumor cerebri with severe papilledema.

Authors:  Simon R Bababeygy; Michael X Repka; Prem S Subramanian
Journal:  J Ophthalmol       Date:  2010-02-16       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.